SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006304
Filing Date
2020-05-11
Accepted
2020-05-11 17:09:52
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20200511x10q.htm   iXBRL 10-Q 1600395
2 EX-31.1 tgtx-20200331xex31d1.htm EX-31.1 17180
3 EX-31.2 tgtx-20200331xex31d2.htm EX-31.2 17961
4 EX-32.1 tgtx-20200331xex32d1.htm EX-32.1 7999
5 EX-32.2 tgtx-20200331xex32d2.htm EX-32.2 7376
  Complete submission text file 0001558370-20-006304.txt   6361220

Data Files

Seq Description Document Type Size
6 EX-101.SCH tgtx-20200511.xsd EX-101.SCH 49664
7 EX-101.CAL tgtx-20200511_cal.xml EX-101.CAL 53254
8 EX-101.DEF tgtx-20200511_def.xml EX-101.DEF 163117
9 EX-101.LAB tgtx-20200511_lab.xml EX-101.LAB 439234
10 EX-101.PRE tgtx-20200511_pre.xml EX-101.PRE 324112
15 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20200511x10q_htm.xml XML 1014309
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 20865962
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences